Canaccord Genuity maintains a 'Hold' on AspenBio Pharma (APPY); Several Moving Parts
Tweet
Share
E-mailGet Alerts APPY Hot Sheet
Price: $3.94 --0%
Rating Summary:
0 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
0 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity maintains a 'Hold' on AspenBio Pharma (NASDAQ: APPY) price target of $2.50.
Analyst, Jeffrey Frelick, said, "We maintain our rating on AspenBio Pharma as we await some visibility into its pivotal trial. APPY recently filed an S-1, highlighting its intention on a capital raise, 1-for-6 reverse stock split, and a business update."
For an analyst ratings summary and ratings history on AspenBio Pharma click here. For more ratings news on AspenBio Pharma click here.
Shares of AspenBio Pharma closed at $0.45 yesterday.
Analyst, Jeffrey Frelick, said, "We maintain our rating on AspenBio Pharma as we await some visibility into its pivotal trial. APPY recently filed an S-1, highlighting its intention on a capital raise, 1-for-6 reverse stock split, and a business update."
For an analyst ratings summary and ratings history on AspenBio Pharma click here. For more ratings news on AspenBio Pharma click here.
Shares of AspenBio Pharma closed at $0.45 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
